Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company LFB S.A.
DescriptionPlasma Factor XI concentrate
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsTreat severe constitutive factor XI deficiency
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today